Suppr超能文献

导致 Menkes 病和枕骨角综合征的 ATP7A 突变的概述和更新。

An overview and update of ATP7A mutations leading to Menkes disease and occipital horn syndrome.

机构信息

Applied Human Molecular Genetics, Kennedy Center, Copenhagen University Hospital, Rigshospitalet, Glostrup, Denmark.

出版信息

Hum Mutat. 2013 Mar;34(3):417-29. doi: 10.1002/humu.22266.

Abstract

Menkes disease (MD) is a lethal multisystemic disorder of copper metabolism. Progressive neurodegeneration and connective tissue disturbances, together with the peculiar "kinky" hair, are the main manifestations. MD is inherited as an X-linked recessive trait, and as expected the vast majority of patients are males. MD occurs because of mutations in the ATP7A gene and the vast majority of ATP7A mutations are intragenic mutations or partial gene deletions. ATP7A is an energy-dependent transmembrane protein, which is involved in the delivery of copper to the secreted copper enzymes and in the export of surplus copper from cells. Severely affected MD patients die usually before the third year of life. A cure for the disease does not exist, but very early copper-histidine treatment may correct some of the neurological symptoms. This study reviews 274 published and 18 novel disease causing mutations identified in 370 unrelated MD patients, nonpathogenic variants of ATP7A, functional studies of the ATP7A mutations, and animal models of MD.

摘要

Menkes 病(MD)是一种致命的铜代谢多系统紊乱疾病。进行性神经退行性变和结缔组织紊乱,以及独特的“卷曲”毛发,是主要表现。MD 作为 X 连锁隐性遗传特征遗传,绝大多数患者为男性。MD 是由于 ATP7A 基因突变引起的,绝大多数 ATP7A 突变是基因内突变或部分基因缺失。ATP7A 是一种能量依赖性跨膜蛋白,参与将铜输送到分泌的铜酶,并将多余的铜从细胞中输出。严重受影响的 MD 患者通常在三岁之前死亡。目前尚无治愈该疾病的方法,但非常早期的铜组氨酸治疗可能纠正一些神经症状。本研究回顾了 370 名无关 MD 患者中已发表的 274 种和新发现的 18 种致病突变、ATP7A 的非致病性变体、ATP7A 突变的功能研究以及 MD 的动物模型。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验